1. Home
  2. UONEK vs JSPR Comparison

UONEK vs JSPR Comparison

Compare UONEK & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Urban One Inc. Class D

UONEK

Urban One Inc. Class D

N/A

Current Price

$4.96

Market Cap

22.4M

ML Signal

N/A

Logo Jasper Therapeutics Inc.

JSPR

Jasper Therapeutics Inc.

HOLD

Current Price

$0.92

Market Cap

23.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UONEK
JSPR
Founded
1980
2018
Country
United States
United States
Employees
1272
22
Industry
Broadcasting
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.4M
23.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
UONEK
JSPR
Price
$4.96
$0.92
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$15.50
AVG Volume (30 Days)
1.7K
651.8K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.44
$0.62
52 Week High
$9.38
$7.19

Technical Indicators

Market Signals
Indicator
UONEK
JSPR
Relative Strength Index (RSI) 38.98 46.41
Support Level $4.78 $0.62
Resistance Level $6.12 $1.12
Average True Range (ATR) 0.21 0.12
MACD -0.00 0.02
Stochastic Oscillator 15.41 54.08

Price Performance

Historical Comparison
UONEK
JSPR

About UONEK Urban One Inc. Class D

Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.

Share on Social Networks: